Bispecific biotech Bambusa and Parkinson’s-focused Aspen slide on trading debuts

Bambusa Therapeutics (BBTX) stock and Aspen Neuroscience (ASPE) stock fell in Nasdaq debuts after raising $168.9M and $140.6M, respectively. Read more here.

CryptoAlerta — análise de criptomoedas e mercado em tempo real